SNCA and Parkinson disease: Although SNCA genetic mutation or overexpression models inducing α-synuclein aggregation may provide useful information on how aggregation can affect neuronal dysfunction, SNCA genetic alterations that induce aggregation may be very rare, or are not naturally occurring Parkinson’s disease-associated mutations in patients, such as α-synuclein truncation.